The 20th edition of BioAsia – The Marquee Healthcare and Life Sciences event, organized by the Government of Telangana, has announced that the coveted Genome Valley Excellence Award for the year 2023 will be conferred upon Prof. Robert S. Langer, in light of his pioneering research that has led to the development of the first commercial mRNA vaccines used for a variety of infectious diseases. Langer is currently the David H. Koch Institute Professor at Massachusetts Institute of Technology (MIT), USA. He is also being acknowledged for his exemplary research in human health, including the detection, monitoring, and treatment of cancer. A veteran in his field, his remarkable contributions to biomedical and therapeutic research include developing long-term and controlled-release drug delivery systems used for a variety of applications including cancer therapy, insulin, and vaccines.
Related Posts
Birla Precision Technologies Rebrands to Drive Growth Across High-Precision and Emerging Sectors
Mumbai, Feb 11: Birla Precision Technologies Limited (BPTL), a pioneer in precision engineering and manufacturing, unveiled a new brand identity…
Think 2026: IBM Makes Digital Sovereignty Operational with General Availability of IBM Sovereign Core
New capabilities help enterprises, governments, and service providers operationalize digital sovereignty with continuous compliance and control across hybrid environments BOSTON,…
Arkel invests INR 100 Cr in Phase 1, Opens Advanced Lift Control Manufacturing Facility
Vadodara, Feb 26: Aligning with the Government of India’s ‘Make in India’ vision, Arkel India on Thursday opened a new manufacturing facility at an investment of…